Cited by 483Nanoplatforms for cancer theranosticsPhotodynamic Therapy Research StudiesNanoparticle-Based Drug Delivery

Recent Advances in Cell Membrane–Camouflaged Nanoparticles for Cancer Phototherapy

Zhen, Xu, Cheng, Penghui, Pu, Kanyi·2019·Small

Abstract

Phototherapy including photothermal therapy (PTT) and photodynamic therapy (PDT) employs phototherapeutic agents to generate heat or cytotoxic reactive oxygen species (ROS), and has therefore garnered particular interest for cancer therapy. However, the main challenges faced by conventional phototherapeutic agents include easy recognition by the immune system, rapid clearance from blood circulation, and low accumulation in target sites. Cell‐membrane coating has emerged as a potential way to overcome these limitations, owing to the abundant proteins on the surface of cell membranes that can be inherited to the cell membrane–camouflaged nanoparticles. This review summarizes the recent advances in the development of biomimetic cell membrane–camouflaged nanoparticles for cancer phototherapy. Different sources of cell membranes can be used to coat nanoparticles uisng different coating approaches. After cell‐membrane coating, the photophysical properties of the original phototherapeutic nanoparticles remain nearly unchanged; however, the coated nanoparticles are equipped with additional physiological features including immune escape, in vivo prolonged circulation time, or homologous targeting, depending on the cell sources. Moreover, the coated cell membrane can be ablated from phototherapeutic nanoparticles under laser irradiation, leading to drug release and thus synergetic therapy. By combining other supplementary agents to normalize tumor microenvironment, cell‐membrane coating can further enhance the therapeutic efficacy against cancer.

Integrity signals

Registry

Crossref · 10.1002/smll.201804105

Cites

152 of 152 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Conventional nanoparticles continue to face difficulties including quick blood circulation clearance, simple immune system recognition, and low target site accumulation.

    “Conventional nanoparticles continue to face a number of difficulties, including quick blood circulation clearance, simple immune system recognition, and low target site accumulation.64”

    From Smart nanoparticles for cancer therapy (2023) · cites this paper as [64]

  • Cell membrane coating has become recognized as a viable means of overcoming the limitations of conventional nanoparticles.

    “Due to the numerous proteins that are present on the surface of cell membranes, cell membrane coating has become recognized as a viable means of overcoming these limitations.64,65”

    From Smart nanoparticles for cancer therapy (2023) · cites this paper as [64]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zhen, X., Cheng, P., & Pu, K.
Affiliations
  • School of Chemical and Biomedical Engineering Nanyang Technological University 70 Nanyang Drive Singapore 637457 Singapore
  • Nanyang Technological University (SG)
Corresponding author
Pu, Kanyi
Venue
Small
Publisher
Wiley
Published
2018-11-20
Volume
15
Issue
1
Pages
e1804105-e1804105
ISSN
  • 1613-6810 (ISSN-L)
  • 1613-6829
OpenAlex
W2900568353
Cited by
483
References
152
Citations by year
2026: 13 · 2025: 38 · 2024: 60 · 2023: 94 · 2022: 90 · 2021: 78 · 2020: 77 · 2019: 33
FWCI
3.83
Type
journal article
Language
en
Open access
closed
Locations
  • Small (publishedVersion)
  • PubMed (publishedVersion)
  • DR-NTU (Nanyang Technological University) (submittedVersion)
Funders
  • Nanyang Technological University (NTUSUG: M4081627.120)
  • Ministry of Education - Singapore (RG133/15 M4011559, 2015‐T1‐002‐091, MOE2016‐T2‐1‐098)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Photodynamic Therapy Research Studies
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords
biomimetic nanoparticles, cancer phototherapy, photothermal therapy, photodynamic therapy, immune evasion, homologous targeting, laser-triggered drug release, tumor microenvironment normalization, reactive oxygen species
MeSH terms
Animals, Cell Membrane, Humans, Neoplasms, Particle Size, Phototherapy, Nanoparticles, Static Electricity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review